(1R,4S)-9-(4-[(4,4'-DIMETHOXYTRITYL)-OXY]-2-CYClOPENTAN-1-YL)-9H-ADENINE
Compound with spectra: 1 NMR
![(1R,4S)-9-(4-[(4,4'-DIMETHOXYTRITYL)-OXY]-2-CYClOPENTAN-1-YL)-9H-ADENINE](/api/compound/HRtgOTb1lkc.png?ph=true&h=300&w=458 "(1R,4S)-9-(4-[(4,4'-DIMETHOXYTRITYL)-OXY]-2-CYClOPENTAN-1-YL)-9H-ADENINE")
| SpectraBase Compound ID | HRtgOTb1lkc |
|---|---|
| InChI | InChI=1S/C31H29N5O3/c1-37-25-13-8-22(9-14-25)31(21-6-4-3-5-7-21,23-10-15-26(38-2)16-11-23)39-27-17-12-24(18-27)36-20-35-28-29(32)33-19-34-30(28)36/h3-17,19-20,24,27H,18H2,1-2H3,(H2,32,33,34)/t24-,27+/m0/s1 |
| InChIKey | DYTLIQTTWKIBIV-RPLLCQBOSA-N |
| Mol Weight | 519.61 g/mol |
| Molecular Formula | C31H29N5O3 |
| Exact Mass | 519.22704 g/mol |
| Enantiomer InChIKey | DYTLIQTTWKIBIV-SQHAQQRYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
9-[4-(DIPHOSPHORYLOXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-ADENINE
P,P'-BIS-[[4-(ADENINE-9-YL)-CYCLOPENT-2-ENYL]-OXYMETHYLPHOSPHONYL]-PHOSPHATE
(1S,3S,4S)-9-(3-HYDROXY-4-[(4,4'-DIMETHOXYTRITYL)-OXY]-CYClOPENT-1-YL)-9H-ADENINE
17;(1R,2S,4S)-4-(9H-ADENIN-9-YL)-2-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL-ACETATE;9-[(1S,3R,4S)-3-ACETOXY-4-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL]-9H-
[(3R,5S)-3-(6-aminopurin-9-yl)-5-[(dimethyl-thexyl-silyl)oxymethyl]-1-cyclopentenyl]methanol
9-[(1'.beta.,3'a.alpha.,4'.beta.)-4'-(Dihydroxyphosphorylmethoxy)-3'-hydroxycyclopentyl}adenine 3',4'-cyclic acid ester
3',4'-CYCLIC-ESTER-OF-9-[(1'-BETA,3'-ALPHA,4'-BETA)-4'-(DIHYDROXYPHOSPHORYLMETHOXY)-3'-HYDROXYCYCLOPENTYL]-ADENINE
(1'R,4'R)-2-AMINO-6-CHLORO-9-[4'-(TRIPHENYLMETHOXYMETHYL)-CYCLOPENT-2'-EN-1'-YL]-PURINE
(S)-1-((2S,3S,4R)-4-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)ethane-1,2-diol
(1R,2S,3R,5R)-3-(6-aminopurin-9-yl)-5-(2-hydroxyethyl)cyclopentane-1,2-diol
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (+)-5'-nor-2'-deoxyaristeromycin and (-)-5'-nor-3'-deoxyaristeromycin | The Journal of Organic Chemistry | 1993 |